[Celiac disease: one step toward therapeutic evolution?].
Cerf-Bensussan
Nadine
N
Heyman
Martine
M
D015704:CD4 Antigens / Q000276:immunology; D002446:Celiac Disease / Q000276:immunology* / Q000628:therapy*; D005903:Gliadin / Q000009:adverse effects / Q000737:chemistry; D005983:Glutens / Q000009:adverse effects / Q000737:chemistry; D006683:HLA-DQ Antigens / Q000276:immunology; D006801:Humans; D010446:Peptide Fragments / Q000009:adverse effects / Q000737:chemistry; D012697:Serine Endopeptidases / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D015704:CD4 Antigens; D006683:HLA-DQ Antigens; C053186:HLA-DQ2 antigen; D010446:Peptide Fragments; D005983:Glutens; D005903:Gliadin; D012697:Serine Endopeptidases
Maladie coeliaque: un premier pas vers une évolution thérapeutique?